Mprex Healthcare
Mprex Healthcare is a Pune, India-based CRO founded in 2009 that provides end-to-end clinical and preclinical research services for nutraceutical, herbal, dietary supplement, ayurvedic, and cosmetic manufacturers globally, serving 320+ clients across 16+ countries.
- Company typePrivate
- Founded2009
- HeadquartersPune, India
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Mprex Healthcare does
Mprex Healthcare Pvt. Ltd. is a Pune, India-based contract research organization (CRO) founded in 2009 that provides end-to-end clinical research and preclinical services for nutraceutical, herbal, dietary supplement, ayurvedic, and cosmetic product companies. The company positions itself as the "No. 1 CRO in India" for nutraceutical research and serves both domestic and overseas enterprise clients who require scientific evidence to substantiate product health and marketing claims. Over 16+ years, Mprex has completed 500+ studies, served 320+ clients across 16+ countries, built a network of 300+ investigators and sites, and produced 260+ publications.
The company's service portfolio spans six core modules — Contract Research/Clinical Trials, In Vitro Studies, Pharmacokinetic Studies, Preclinical Services, Cosmetic & Dermatology Studies, and Project Management — applied across 11 therapeutic research areas including diabetes, metabolic health, cardiovascular, oncology, sports nutrition, and dermatology. Its technical infrastructure includes GLP and non-GLP preclinical laboratories, in vitro and in vivo research facilities, a bioanalytical research facility, and pharmacokinetic/bioavailability study capabilities. The company operates a proprietary quality management framework called Concentric Quality Intelligence (CQI) and holds ISO 9001 certification.
Mprex generates revenue through custom, project-based professional services engagements priced by treatment duration, sample size, parameters evaluated, and study design. Its go-to-market is direct enterprise sales targeting nutraceutical, dietary supplement, herbal, ayurvedic, and cosmetic manufacturers globally. The company also operates Mprex Biotech, a sub-brand delivering agricultural research services, and has registered the Mprex Foundation. Mprex is privately held and founder-controlled by CEO & Founder Dr. Dheeraj Nagore and Managing Director Dr. Gayatri Ganu, with no disclosed external funding or institutional investor backing.
Mprex Healthcare firmographics
Firmographics- Name
- Mprex Healthcare
- Legal name
- Mprex Healthcare Pvt. Ltd.
- Website
- https://mprex.in
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Mprex Healthcare is a Pune, India-based CRO founded in 2009 that provides end-to-end clinical and preclinical research services for nutraceutical, herbal, dietary supplement, ayurvedic, and cosmetic manufacturers globally, serving 320+ clients across 16+ countries.
- Ownership category
- akta.pro rank
Mprex Healthcare industry classification
Industry- Product category
- Contract Research Organization (CRO) / Clinical Research Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC), Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)
Keywords
Where Mprex Healthcare is headquartered
LocationHeadquarters
- HQ city
- Pune
- HQ country
- India
- HQ region
- Asia
Offices2 records
Markets served
Mprex Healthcare business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Clinical Trial Services: Full-service clinical trial offerings including pilot studies, proof of concept studies, and large multicentric studies for evaluating efficacy and safety in humans. Services range from protocol design to manuscript publishing for nutraceuticals, herbal, dietary supplements, and ayurveda products.
- Preclinical Services: Preclinical and toxicity studies in GLP and non-GLP laboratories, including toxicological studies, proof of concept studies, and mechanism of action investigations for natural product research.
- Pharmacokinetic Studies: Bioavailability and pharmacokinetic studies for herbal extracts, natural ingredients, and protein supplements to substantiate product claims.
- In Vitro Studies: Laboratory-based studies evaluating safety, efficacy, and mechanisms of action for nutraceuticals, herbal remedies, Ayurvedic formulations, and cosmetic products.
- Cosmetic and Dermatology Studies: Clinical studies in dermatology for dermatitis, psoriasis, acne, skin allergies, and anti-aging claim-substantiating studies for skin and hair care products.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing for clinical trial services |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels8 records
Mprex Healthcare product offering
Product offeringCore offering
Mprex Healthcare is a Contract Research Organization (CRO) providing end-to-end clinical and preclinical research services for nutraceutical, herbal, dietary supplement, ayurvedic, and cosmetic companies. Services range from protocol design through manuscript publishing and cover clinical trials, in vitro studies, pharmacokinetic/bioavailability studies, preclinical toxicity studies, cosmetic and dermatology trials, and full project management. The company operates GLP and non-GLP laboratories and serves both domestic Indian clients and overseas customers globally.
Product overview
Mprex Healthcare operates as a unified contract research organization (CRO) platform offering end-to-end clinical research services for nutraceuticals, herbal products, dietary supplements, Ayurvedic formulations, and cosmetics. The core service portfolio consists of six interconnected modules: Contract Research/Clinical Trials (featuring pilot to multicentric studies), In Vitro Studies, Pharmacokinetic Studies, Preclinical Services, Project Management, and Cosmetic & Dermatology Studies. These services are applied across eleven specialized therapeutic research areas including Diabetes, Metabolic Health, Digestive Health, Cardiovascular, Healthy Aging, Dermatology & Trichology, Bone/Joint/Muscle Health, Sports Nutrition, Dental & Oral Care, and Oncology. The company delivers services from protocol design through manuscript publishing, serving both domestic and overseas clients in the nutraceutical industry.
Differentiator
Problem solved
Functional benefit
Brands
- Mprex Biotech: Delivers research in the agriculture industry.
Products and services
- Contract Research (Clinical Trials) Full-service clinical trial management from pilot studies to large multicentric studies, evaluating efficacy and safety in humans for nutraceuticals, herbal, dietary supplements, ingredients, and ayurveda products. Includes customized study designs to validate product-related health and marketing claims.
- In Vitro Studies Laboratory-based studies evaluating safety, efficacy, and mechanisms of action for nutraceuticals, herbal remedies, Ayurvedic formulations, and cosmetic products using cell culture techniques, molecular biology assays, and advanced imaging technologies.
- Pharmacokinetic Studies Bioavailability and pharmacokinetic (PK) studies for herbal extracts, natural ingredients, and protein supplements. Assesses absorption, distribution, metabolism, and excretion parameters including AUC and Cmax for optimal dosing strategies and product claim substantiation.
- Preclinical Services Comprehensive preclinical and toxicity studies in GLP and non-GLP laboratories, including toxicological studies, proof of concept studies, and preclinical investigations with animal models supported by histopathology and biomarker analysis.
- Project Management End-to-end clinical trial project management ensuring adherence to timelines, budgets, and regulatory requirements. Includes proactive risk management, transparent communication, and quality assurance throughout the research process.
- Cosmetic & Dermatology Studies Clinical studies in dermatology for dermatitis, psoriasis, acne, skin allergies, and anti-aging claim-substantiating studies. Includes safety and efficacy testing for cosmetics, haircare products, and non-invasive beauty devices, supported by a dedicated skin and hair laboratory.
Quantifiable outcome
- 500+ studies completed
- +3 more outcomes
Companies that use Mprex Healthcare
Customer profileNamed customers3 records
Segments6 records
Ideal customer profiles3 records
Mprex Healthcare technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Mprex Healthcare partnerships and signals
Strategic signalScale indicators7 records
Recent moves8 records
Expansion highlights5 records
Mprex Healthcare competitors and assessment
Company assessmentBroad incumbents
- Syngene International: Large publicly listed Indian CRO/CDMO serving pharma, biotech, and consumer health clients globally with discovery, development, and clinical services. Overlaps significantly with Mprex in clinical CRO and nutraceutical-adjacent work but at vastly larger scale and broader scope.
- Celerion: Global clinical CRO specializing in early-stage clinical pharmacology, bioequivalence, and bioanalytical studies for pharma and consumer health sponsors. Comparable in clinical CRO service model and bioavailability expertise similar to Mprex's pharmacokinetic offerings.
- Charles River Laboratories: Global CRO with preclinical, clinical, and manufacturing services across pharma, biotech, and consumer health. Comparable in the preclinical/GLP and clinical trial services Mprex provides, but at a much larger, more diversified scale.
- Eurofins Scientific: Global contract laboratory and CRO with extensive bioanalytical, clinical, cosmetic testing, and nutraceutical testing services across many countries. Overlaps with Mprex in clinical research and bioanalytical/cosmetic services but operates as a broad multi-vertical services platform.
Direct peers
- Anthem BioSciences: India-based CRO/CDMO offering preclinical, clinical, and bioanalytical services across pharma, nutraceutical, and biotechnology sponsors. Closely comparable to Mprex across the preclinical-to-clinical continuum and overlapping therapeutic research areas.
- Cliantha Research: India-headquartered CRO with clinical research, bioanalytical, and dermo-cosmetic capabilities serving nutraceutical, pharmaceutical, and consumer health sponsors. Closely matches Mprex's service mix (clinical + preclinical + cosmetic) and similar mid-tier Indian CRO positioning.
- Lambda Therapeutic Research: Indian CRO offering full-service clinical development, bioanalytical, and clinical pharmacology services with multinational site footprint. Comparable to Mprex in clinical CRO focus and ability to run claim-substantiation studies for nutraceutical/pharma sponsors.
- Veeda Clinical Research: India-based CRO offering bioavailability, bioequivalence, clinical, and nutraceutical/dietary supplement research across global sites. Most direct comparable to Mprex given overlapping nutraceutical/clinical services, similar headcount scale, and India-centric operations targeting multinational sponsors.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Mprex Healthcare social profiles
Digital presenceMprex Healthcare compliance and trust
Trust signalCompliance1 record
Mprex Healthcare financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mprex Healthcare leadership team
Management profileNumber of profiles
Profiles2 records
Mprex Healthcare funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mprex Healthcare M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mprex Healthcare
What does Mprex Healthcare do?
Mprex Healthcare is a Contract Research Organization (CRO) providing end-to-end clinical and preclinical research services for nutraceutical, herbal, dietary supplement, ayurvedic, and cosmetic companies. Services range from protocol design through manuscript publishing and cover clinical trials, in vitro studies, pharmacokinetic/bioavailability studies, preclinical toxicity studies, cosmetic and dermatology trials, and full project management. The company operates GLP and non-GLP laboratories and serves both domestic Indian clients and overseas customers globally.
Is Mprex Healthcare a public or private company?
Mprex Healthcare is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Mprex Healthcare founded?
Mprex Healthcare was founded in 2009. It employs 51 to 100 people.
Where is Mprex Healthcare based?
Mprex Healthcare is headquartered in Pune, India, in the Asia region.
How does Mprex Healthcare make money?
Five revenue lines are on record. Clinical Trial Services are the primary driver. The others are preclinical Services, pharmacokinetic Studies, in Vitro Studies and cosmetic and Dermatology Studies.
Who are Mprex Healthcare's main competitors?
Broad incumbents on record are Syngene International, Celerion, Charles River Laboratories and Eurofins Scientific. Direct peers are Anthem BioSciences, Cliantha Research, Lambda Therapeutic Research and Veeda Clinical Research.
Does Mprex Healthcare have an API?
No public API is recorded for Mprex Healthcare.
What industry is Mprex Healthcare in?
Mprex Healthcare's product category is Contract Research Organization (CRO) / Clinical Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAC, Toxicology & Safety Assessment CROs (GLP). Its NAICS code is 54171 and its SIC code is 8731.